Treatment of Myasthenia Gravis Patients with COVID-19: Review of the Literature
Coronavirus disease 2019 (COVID-19), caused by the late 2019 outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes a respiratory disease which could put myasthenia gravis (MG) patients at a greater risk of developing severe disease course, since infections and some drug...
Main Authors: | Sven Županić, Ines Lazibat, Maja Rubinić Majdak, Mia Jeličić |
---|---|
Format: | Article |
Language: | English |
Published: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2021-01-01
|
Series: | Acta Clinica Croatica |
Subjects: | |
Online Access: | https://hrcak.srce.hr/file/393749 |
Similar Items
-
New‐onset myasthenia gravis after novel coronavirus 2019 infection
by: Amirmasoud Taheri, et al.
Published: (2022-06-01) -
New acute onset of ocular myasthenia gravis after COVID-19 vaccine: A case report
by: Himani T Chaturvedi, et al.
Published: (2023-01-01) -
Physiotherapy in myasthenia gravis
by: Klaudia Kwiatkowska, et al.
Published: (2018-12-01) -
Myasthenia Gravis Exacerbation Following COVID-19 Vaccine: A Case Report
by: Thoybah Yousif Ibrahim Gabralla, et al.
Published: (2023-03-01) -
Myasthenia gravis and sugammadex: A case report and review of the literature
by: Sujana Dontukurthy, et al.
Published: (2020-01-01)